contrast A closer look at how cost-share subsidized members use prescription drugs and what plan sponsors can do to manage risk and costs
|
|
- Erik Barnett
- 5 years ago
- Views:
Transcription
1 DEFINING contrast A closer look at how cost-share subsidized members use prescription drugs and what plan sponsors can do to manage risk and costs The public exchange has dominated health care headlines since its inception in Enrollment for 2017 is underway and it s top of mind for many health plans. Though the future of the public exchange is unclear, one thing is certain it has offered a novel opportunity to analyze a new type of health care consumer. Serving more than 1 in 6 members who purchase benefits through the public exchange, Prime Therapeutics (Prime) has unique insight into this population s use of prescription drugs. In this report, we analyze 18 months of data from an average of 1.9 million public exchange members to explore one distinct subset of the population, members who receive cost-share subsidies. As the most recent data illustrates, drug utilization and spend deviate for this population opening the door for targeted strategies to mitigate risk, optimize outcomes and manage costs. Cost-share subsidies and the lower-income members receiving these subsidies haven t received as much attention as premium subsidies. Our analysis shows that this population uses drugs differently, and with their significant cost impact, they merit careful examination from plan sponsors. In this report, we delve into data from 1.9 million of Prime s public exchange members receiving cost-share subsidies, from January 2015 to June 2016, to explore: How lower-income members use prescription medicine How this use varies from public exchange members without cost-share subsidies and commercial members How risk management programs are changing, and how health plans can start to plan for including prescription drugs into risk
2 DEFINING cost-share subsidies As of March, more than 85 percent of the 11 million people with coverage through the public exchanges were receiving premium subsidies. 1 But premiums aren t the only health care costs subsidized through the Affordable Care Act (ACA). More than 60 percent of Prime s members receiving coverage through the public exchanges also receive cost-share subsidies. Cost-share subsidies help to reduce individuals out-of-pocket costs for covered health plan services, including prescription drugs. To receive cost-share subsidies, an individual s income must be less than 250 percent of the federal poverty level (FPL). 2 For 2017 plans, this translates to $29,700 for a single person and $60,750 for a family of four. The actuarial value (the percent of total costs the health plan pays) for cost-share subsidized plans can reach as high as 100 percent for certain individuals. 2 Cost-share subsidies are only available for silver plans. Figure 1: Public exchange cost-share subsidy requirements and actuarial values (2017) 2 Income level (% of FPL) Actuarial level (average % of plan-paid costs) Out-of-pocket maximum (individual/family) 250%+ (no benefit subsidy) 70% $7,150/$14, % 200% to 250% 73% (AV73) $5,700/$11, % 150% to 200% 87% (AV87) $2,350/$4, % 100% to 150% 94% (AV94) $2,350/$4, % Total % of public exchange members receiving cost-share subsidies 60.3% % of total Prime public exchange membership members receiving cost-share subsidies 60.3% More than 60 percent of public exchange members receive cost-share subsidies that decrease out-of-pocket costs. 2
3 DEFINING demographics Members receiving cost-share subsides are, on average, 3.5 percent (1.4 years) older than public exchange members not receiving cost-share subsidies. They re also nearly 9 percent more likely to be female. From 2014, (the first full year of exchange data), like the rest of the public exchange population, age for this group has trended downward more than one year. However, the high proportion of female enrollees has remained roughly the same. Figure 2a: Cost-share subsidized public exchange member demographics Member group Average age % female Public exchange* % Cost-share subsidized public exchange members % *Excluding members receiving benefit subsidies Figure 2b: Cost-share subsidized public exchange member demographics by actuarial value Member group Average age % female AV % AV % AV % AV = Actuarial value 9% 1.4 Public exchange members receiving cost-share subsidies are 9% more likely to be female than those not receiving cost-share subsidies. Public exchange members receiving cost-share subsidies are 1.4 years older, on average than those not receiving cost-share subsidies. 3
4 DEFINING key prescription drug metrics and comparison Public exchanges members receiving cost-share subsidies use more prescription than those who do not, but fewer of these are specialty medicines. Despite this lower use of specialty drugs, benefit-subsidized members drove higher overall drug spend 13 percent greater than those without cost-share subsidies. This spend results from a higher prevalence of chronic conditions such as high blood pressure and diabetes. Despite a decline in utilization nearly 10 percent from 2014, per member per month (PMPM) spend was up more than 40 percent. Use and spend by actuarial value Use and spend patterns vary further when analyzed plan actuarial value (AV). While all levels drove higher spend than public exchange members without cost-share subsidies, utilization for AV73 plan members was slightly lower at 4.7 percent. However, higher specialty utilization from AV73 members drove higher overall PMPM spend compared to other cost-share subsidized groups. As actuarial values rose, we saw a slight increase in 90-day supply utilization, which helped drive higher per member per year utilization but kept PMPM spend, comparatively speaking, in check. Use and spend compared to commercial membership Although the drugs and categories varied, overall use and spend for cost-share subsidized members for the first half of 2016 followed a trend cycle typical to Prime s commercial and non-cost-share subsidized populations. Both started lower than 2015 in January of 2016, then climbed upward. When each month of 2016 was compared to the same month in 2015, utilization and spend were both trending higher. Figure 3a: Utilization, channels and spend Despite lower use of specialty drugs, cost-share subsidized members drove 13% higher overall drug spend. Cost-share subsidized public exchange Gross PMPM spend $ % Utilization (per member per year) % Specialty utilization % Specialty spend as a % of total spend 28% 12.6% 90-day supply utilization 34.5% 1.2% Cost-share subsidized vs. public exchange* *Excluding members receiving cost-share subsidies 4
5 Figure 3b: Utilization, channels and spend for cost-share subsidized public exchange members by AV AV73 AV84 AV94 Gross PMPM spend $ $ $ Utilization (per member per year) Specialty spend as a % of total spend 30.1% 29.5% 27.6% 90-day supply utilization 33.9% 34.1% 35.2% As AV increased, so did utilization. AV94 members used nearly 13% more prescriptions than AV73 members, due in part to higher 90-day utilization. Specialty vs. traditional Members receiving cost-share subsidies used fewer specialty medicines and spent less on them (as a percent of total spend) than public exchange members without subsidized cost-share. But that doesn t mean spend for expensive specialty medicines was low. Drug costs for conditions such as hepatitis C, HIV and autoimmune diseases still drastically outpaced utilization, with a specialty spend ratio nearly 60 times that of specialty drug utilization. Specialty use and spend varied greatly within AV groups. As AV increased, specialty utilization and spend as percent of overall spend declined. This may be partially due to the higher percentage of females in the population along with economic factors limiting specialty drug availability. HIV was the third-highest spend category for this group, and according to the Centers for Diseases Control and Prevention, men account for more than 76 percent of people living with HIV. 3 Traditional medicine use was higher for members receiving cost-share subsidies, particularly for diabetes drugs. 40% increased Despite a decline in utilization from 2014, PMPY spend for cost-share subsidized members more than 40%. 5
6 DEFINING trends in utilization High blood pressure medicines were the highest utilized both inside and outside of the public exchange. But the similarities paused there. Ranking of the next six categories varied. Pain, diabetes and seizure medicines ranked higher for cost-share subsidized members than other public exchange members and commercial members. Depression, high cholesterol, and estrogens and osteoporosis medicines ranked lower. Gastrointestinal disorders, respiratory and ADHD mirrored other populations. Utilization of the most expensive drugs (as measured by PMPM spend) looked very different for cost-share subsidized exchange members. This subgroup outpaced commercial members by at least 100 percent for all of the top 10 drugs. The mostly drastic utilization differences were seen on a PMPM basis in hepatitis C blockbusters Harvoni and Sovaldi, at 200 and 400 percent, respectively. Top HIV drug utilization also surpassed commercial use by more than 200 percent for Atripla, Stribild and Truvada. When compared with other public exchange members, cost-share subsidized members had moderately higher use of Harvoni (hepatitis C), Humira Pen (autoimmune), and Lantus Solostar and Novolog FlexPen (diabetes). Use of HIV drugs Truvada and Atripla was lower. Figure 4: Top categories by utilization High blood pressure medicines was the top therapeutic category for utilization inside and outside the public exchange. 6 Therapeutic categories Cost-share subsidized public exchange utilization PMPY Public exchange* drug category utilization ranking 1. High blood pressure Pain Depression Diabetes High cholesterol Seizure Estrogens and osteoporosis 8. Gastrointestinal disorders Respiratory Attention deficit hyperactivity disorder (ADHD) *Excluding members receiving cost-share subsidies **Excluding public exchange members Commercial** drug category utilization ranking
7 Figure 5: Utilization of top drugs by spend Drugs Cost-share subsidized public exchange utilization PMPM Cost-share subsidized vs. public exchange* 1. Harvoni (HCV) % 200% 2. Humira Pen (auto) % 120% 3. Sovaldi (HCV) = 400% 4. Atripla (HIV) % 233% 5. Enbrel Sureclick (auto) = 100% 6. Stribild (HIV) = 300% 7. Truvada (HIV) % 225% 8. Lantus Solostar (diabetes) % 205% 9. Novolog Flexpen (diabetes) % 192% 10. Crestor (cholesterol) % 100% Cost-share subsidized vs. commercial** *Excluding members receiving cost-share subsidies **Excluding public exchange members Cost-share subsidized public exchange member PMPM utilization for the top 10 highest-spend drugs outpaced commercial members %. 7
8 DEFINING trends in spend The top 10 drug categories for cost-share subsidized public exchange, public exchange not receiving cost-share subsidies and commercial members by spend were identical, with four being specialty drug categories. The rankings, however, varied. For cost-share subsidized members, diabetes topped the list. Hepatitis C was second, two places higher than other public exchange and commercial members. While first for other public exchange members, HIV came in third for members receiving cost-share subsidies. Diabetes: Driving disproportionately higher costs Research has proven the correlation between lower incomes and higher diabetes prevalence. A CDC study showed that diabetes rates are 50 to 65 percent higher for poor or near-poor adults (those earning less than two times the FPL), when compared to those earning a high income (defined as four times the FPL or higher). 4 Prime s analysis confirmed the CDC s finding diabetes spend for the cost-share subsidized public exchange membership was 33 percent higher than any other drug category, and higher than any category for any other population analyzed. Both diabetes utilization and spend trended upward over the 18-month analysis period. More than 70 percent of diabetes spend came from members over 50 years of age. Hepatitis C: Spend trending downward, but still high Although hepatitis C spend showed a decline, it still ranked second in spend by category for the period studied. Harvoni spend, though also trending downward, accounted for the highest cost of any drug at $7.71 PMPM, despite use by just 292 in every 100,000 members. Diabetes spend for Prime s cost share subsidized public exchange membership was 33% higher than any other drug category. 8
9 Figure 6: Top drug categories by PMPM spend Therapeutic categories Cost-share subsidized public exchange PMPM Public exchange* drug category spend ranking 1. Diabetes $ Hepatitis C $ HIV $ Autoimmune $ Pain $ Cancer (pills) $ Respiratory $ Multiple sclerosis $ Cholesterol $ ADHD $ Commercial** drug category spend ranking More than 70% of diabetes drug spend, the top drug category by spend, came from members ages 50 and older. *Excluding members receiving benefit subsidies **Excluding public exchange members Figure 7: Top drugs by PMPM spend Drugs Cost-share subsidized public exchange Cost-share subsidized vs. public exchange* Cost-share subsidized vs. commercial** 1. Harvoni (HCV) $ % 200% 2. Humira Pen (Auto) $ % 120% 3. Sovaldi (HCV) $2.30 = 400% 4. Atripla (HIV) $ % 233% 5. Enbrel Sureclick (Auto) $1.91 = 100% 6. Stribild (HIV) $1.71 = 300% 7. Truvada (HIV) $ % 225% 8. Lantus Solostar (Diabetes) $ % 205% 9. Novolog Flexpen (Diabetes) $ % 192% 10. Crestor (Cholesterol) $1.14 3% 100% HIV was the top category by spend for members under 50 years of age. *Excluding members receiving cost-share subsidies **Excluding public exchange members 9
10 DEFINING risk adjustment Risk adjustment is one of three ACA-related programs that the U.S. Department of Health and Human Services (HHS) employs to prevent adverse selection and risk selection. The program works by redistributing funds from plans with a disproportionate amount of lower-risk enrollees to plans with greater proportion of higher-risk enrollees. The goal is to encourage health insurers to compete based on plan value and efficiency, instead of competing to attract healthier enrollees. Risk adjustment extends beyond the public exchange. All non-grandfathered plans in the individual and small group insurance markets, inside and outside of the exchanges, participate. Unlike reinsurance and risk corridors, which were in place from 2014 to 2016, risk adjustment is a permanent program. As of 2017, the federal government will administer the program for all states. Risk scores Each plan enrollee is assigned a risk score based on their age, sex, diagnosis and the relative expenditures a plan is likely to incur for that individual. A plan s risk score, and the resulting adjustment payment transfers, are based on the average risk score of individuals with a plan across a defined geographic rating area. In the 2018 benefit year, the HHS model used to calculate risk adjustment will expand to include information about prescription drug utilization. The addition of prescription information brings a whole new level of complexity for the Centers for Medicare & Medicaid Services (CMS). CMS will be pushed to develop a methodology to account for drugs having multiple indications. The agency will also have to account for: The availability, or lack of, outpatient drug data Added cost and administrative burdens Sensitivity of risk adjustment to variations in prescription drug utilization Gaming or pervasive incentives to prescribe high cost medicines when not indicated 10
11 CMS will use 10 principles to evaluate conditions and corresponding medicines into its risk calculations in 2018: 1 Clinically meaningful 2 Predict total medical and pharmacy costs 3 Affect payment should have meaningful sample size 4 Member illness and medicine for condition should be included, but medicines not meaningful to that specific condition should not 5 Should not reward overprescribing From a pharmacy perspective, there are still many outstanding questions about the new risk adjustment methodology. How will CMS incorporate pharmacy within the medical risk calculation? Is it one score or two? If a separate score is used, is it based on (the class of drugs, the disease severity associated with a specific drug, a hybrid, etc.)? How can a single NDC be assigned to a drug that is prescribed for multiple diagnoses? With such significant downstream administrative and financial implications, it s imperative that CMS continues to use data to drive decisions. 6 Providers should not be penalized for prescribing any approved drug 7 Classification system should be internally consistent 8 Classification should assign all national drug codes (NDCs) 9 Classification should assign NDCs to only one medicine claim 10 Discretionary drug categories should be excluded from payment therapeutic categories included in risk: Hepatitis C HIV Autoimmune Cancer Diabetes High cholesterol therapeutic categories not included in risk: Respiratory High blood pressure Pain (NSAID) Depression CMS is choosing to focus only on high-cost medicines for risk score calculations. Many of the top-utilized drugs, such as high blood pressure, pain and high cholesterol drugs, will not be included. 11
12 Risk score variation within the public exchange When compared to the broader public exchange, we can expect high pharmacy risk scores, in general, for members receiving cost-share subsidies. This assumption can be attributed to a higher percentage of females (results in higher risk score using current formulas) and higher utilization of drug categories, such as diabetes, that will be factored into future risk scores. Given the higher financial liability placed on plans covering cost-share subsidized members, the associated risk scores will always be inflated. With the current risk adjustment payment model, however, having more benefit-subsidized members does not necessarily equate to higher total costs. Informed plans that actively manage this population may come out ahead. RISK SCORES UTILIZATION PERCENT FEMALE 12
13 looking forward Though the future of the public exchanges is unclear, understanding lower income members is critical for plan sponsors. Our analysis highlights this population s greater need for medicine and the higher resulting expenses. By understanding their unique prescription drug use and spend patterns, health plan sponsors can better manage risk, promote positive health outcomes, and design sustainable, affordable benefit plans. As health care continues to evolve, Prime will continue to offer innovative approaches to managing risk and driving value for members and plan sponsors. Through our foundational integration with our Blue Cross and Blue Shield Plan owners and clients, we have unique connections that provide a holistic view of health care. These connections allow us to partner on building solutions, integrating data and working together toward a shared goal helping members get the medicine they need to feel better and live well at an affordable cost. For the latest information on drugs, trends and the pharmacy industry, or to learn more about Prime s pharmacy benefit solutions, visit PrimeTherapeutics.com. 13
14 KEY TERMS Adverse selection: occurs when consumers who are most in need of health care are more likely to purchase insurance, which can lead to higher premiums and market disruption. Risk selection: occurs when insurers have an incentive to avoid enrolling people likely to require costly medical care, which can spur competition for healthier members instead of plan value. Reinsurance: HHS program that provides funding to health plans that incur high claims costs for enrollees, reducing incentives for plans to avoid high-cost individuals and stabilizing premiums. Who participates: issuers and third-party administrators on behalf of group plans contribute funding; non-grandfathered individual market plans are eligible for payments. Risk corridors: HHS program that limits health plan gains/losses through federal payments/charges if allowed costs and above/below a target amount, encouraging competition by limiting risk. Who participates: Insurance plans certified by the HIM, a.k.a., Qualified Health Plans. Grandfathered plans: health plans in existence at the time the ACA was enacted in March Actuarial value: amount paid by the health insurance plan, representing premium and cost share (deductible, copay, coinsurance, and out-of-pocket maximum). Benefit subsidies: reductions in individuals out-of-pocket cost share for covered health plan services, individuals must meet certain income requirements (less than 250 percent of the federal poverty line or less than 300 percent for members of a recognized Native American tribe, band or nation). Public exchange members: people enrolled in a public health insurance exchange plan with pharmacy benefits provided by Prime, excluding members receiving benefit subsidies, when noted. Commercial members: people enrolled in health insurance plans provided by an employer or other organization with pharmacy benefits provided by Prime (excluding Medicare and Medicaid). Gross PMPM spend: spend for drugs covered under the pharmacy benefit, including plan-paid and member out-of-pocket costs, not inclusive of rebates, divided into a per member per month cost. Unadjusted claims: any pharmacy claim filled, no matter the length of the supply, is counted as one claim. Adjusted claims: claim counts are attributed to days of supply, with one prescription counted for every 30 days of supply (e.g., if claim is for 90-day supply, it would be counted as three prescriptions). Specialty: all drugs managed through Prime s specialty pharmacy program. Traditional: all drugs not on Prime s specialty drug management list. 14
15 DATA AND INSIGHTS This report looks closely at changes in drug costs, utilization and other key measures that affect pharmacy spending. Data from Jan. 1, 2015 June 30, 2016, is compared across actuarial-value levels within the benefit-subsidized public exchange membership; Prime s public exchange membership as a whole, excluding members receiving benefit subsidies; and Prime s commercial membership. Unless otherwise noted, all insights come from Prime s analyses. Pharmacy trend data represents adjusted public exchange and commercial claims processed in 2015 and from Jan. 1 June 30, Claim counts are attributed based on days of supply, with one prescription counted for every 30 days of supply. To calculate data within this report, we used an average membership for benefit-subsidized public exchange, public exchange and commercial populations. REFERENCES 1 Norris, L. (2016, August 16). The ACA s cost-sharing subsidies. healthinsurance.org. Accessed at: healthinsurance.org/obamacare/the-acas-cost-sharing-subsidies/. 2 Claxton, F. (2015, February 11). Cost-sharing subsidies in federal marketplace plans. The Henry J. Kaiser Family Foundation. Accessed at: kff.org/health-costs/ issue-brief/cost-sharing-subsidies-in-federal-marketplace-plans-2016/. 3 Centers for Disease Control and Prevention. (2016, Sept. 16). HIV among men in the United States. Accessed at: cdc.gov/hiv/group/gender/men/. 4 Centers for Disease Control and Prevention. (2013, Nov. 22). Diabetes United States, 2006 and Accessed at: cdc.gov/mmwr/preview/mmwrhtml/ su6203a17.htm. All brand names are the property of their respective owner. 15
16 About Prime Therapeutics Prime Therapeutics (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minnesota, Prime serves just over 22 million people. It is collectively owned by 14 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation. Prime Therapeutics LLC Corporate Center Drive, Eagan, MN PrimeTherapeutics.com 6244-A Prime Therapeutics LLC 12/16 YouTube.com/PrimeTherapeutics Twitter.com/Prime_PBM LinkedIn.com/company/prime-therapeutics
Risk adjustment is an important opportunity to ensure the sustainability of the exchanges and coverage for patients with chronic conditions.
RISK ADJUSTMENT Risk adjustment is an important opportunity to ensure the sustainability of the exchanges and coverage for patients with chronic conditions. If risk adjustment is not implemented correctly,
More information2016 Drug Trend Report Executive Summary
COMMERCIAL 2016 Drug Trend Report Executive Summary EXPRESS SCRIPTS 2016 DRUG TREND REPORT COMMERCIAL EXECUTIVE SUMMARY 1 Driving undeniable value for plans and patients in 2016 The issue of rising drug
More information2014 and Beyond. This timeline explains how and when the Affordable Care Act (ACA) provisions will be implemented over the next few years.
December This timeline explains how and when the Affordable Care Act (ACA) provisions will be implemented over the next few years. Get Covered Illinois, the Official Health Marketplace of Illinois While
More informationNo Limit: Medicare Part D Enrollees Exposed to High Outof-Pocket Drug Costs Without a Hard Cap on Spending
No Limit: Medicare Part D Enrollees Exposed to High Outof-Pocket Drug Costs Without a Hard Cap on Spending Juliette Cubanski, Tricia Neuman, Kendal Orgera, and Anthony Damico Since 2006, the Medicare Part
More informationFactors Affecting Individual Premium Rates in 2014 for California
Factors Affecting Individual Premium Rates in 2014 for California Prepared for: Covered California Prepared by: Robert Cosway, FSA, MAAA Principal and Consulting Actuary 858-587-5302 bob.cosway@milliman.com
More informationBringing Health Care Coverage Within Reach
Measuring the Financial Assistance Available through Covered California that is lowering the Cost of Coverage and Care Introduction The Affordable Care Act (ACA) helped cut the rate of the uninsured by
More information2013 Milliman Medical Index
2013 Milliman Medical Index $22,030 MILLIMAN MEDICAL INDEX 2013 $22,261 ANNUAL COST OF ATTENDING AN IN-STATE PUBLIC COLLEGE $9,144 COMBINED EMPLOYEE CONTRIBUTION $3,600 EMPLOYEE OUT-OF-POCKET $5,544 EMPLOYEE
More informationThe Affordable Care Act: Time to Prepare for 2014 and Beyond
The Affordable Care Act: Time to Prepare for 2014 and Beyond Howard Van Mersbergen Vice President of Employee Benefits, Christian Schools International Brian C. Meekhof Benefits Administrator, Christian
More informationInsights into pharmacy benefit management, drug trend and the future
Insights into pharmacy benefit management, drug trend and the future 1 Where does your health care dollar go? 2 Pharmacy share of total health spend 25% 21% 20% 19% 15% 10% 10% 5% 0% Retail Drugs as a
More informationActuarial equivalence will be confirmed via an actuary s letter from the health insurance issuer to the State
Essential Health Benefits Draft proposed rules on November 20, 2012 outlining the EHBs that qualified health plans must cover Based on section 1302 of the Affordable Care Act 10 EHB categories (emergency,
More informationSeptember 2013
September 2013 Copyright 2013 Health Care Cost Institute Inc. Unless explicitly noted, the content of this report is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 3.0 License
More informationCity of Los Angeles Periodic Utilization Report 3rd Quarter 2017 (10/1/2016 9/30/2017)
Dr. Craig Collins, MD, MBA, FACS General and Minimally Invasive Surgery Physician Marketing Leader, Los Angeles Metro Area Associate Clinical Professor, UCLA Geffen School of Medicine City of Los Angeles
More informationNEWLY ENROLLED MEMBERS IN THE INDIVIDUAL HEALTH INSURANCE MARKET AFTER HEALTH CARE REFORM: THE EXPERIENCE FROM 2014 AND 2015
NEWLY ENROLLED MEMBERS IN THE INDIVIDUAL HEALTH INSURANCE MARKET AFTER HEALTH CARE REFORM: THE EXPERIENCE FROM 2014 AND 2015 Newly Enrolled Members in the Individual Health Insurance Market After Health
More informationThe Patient Protection and Affordable Care Act s (ACA s) Risk Adjustment Program: Frequently Asked Questions
The Patient Protection and Affordable Care Act s (ACA s) Risk Adjustment Program: Frequently Asked Questions Katherine M. Kehres Presidential Management Fellow October 4, 2018 Congressional Research Service
More informationUnderstanding Patient Access in Health Insurance Exchanges. August 2014 avalerehealth.net
Understanding Patient Access in Health Insurance Exchanges August 2014 avalerehealth.net Agenda Exchange Basics and Patient Protections Formulary Coverage Cost-Sharing Transparency 2 Exchange Basics and
More informationThe Center for Hospital Finance and Management
The Center for Hospital Finance and Management 624 North Broadway/Third Floor Baltimore MD 21205 410-955-3241/FAX 410-955-2301 Mr. Chairman, and members of the Aging Committee, thank you for inviting me
More informationFinancial Reporting Implications Under the Affordable Care Act
Financial Reporting Implications Under the Affordable Care Act Laurel A. Kastrup, MAAA, FSA Chairperson, Health Practice Financial Reporting Committee Darrell D. Knapp, MAAA, FSA Member, Health Practice
More informationACA impact illustrations Individual and group medical New Jersey
ACA impact illustrations Individual and group medical New Jersey Prepared for and at the request of: Center Forward Prepared by: Margaret A. Chance, FSA, MAAA James T. O Connor, FSA, MAAA 71 S. Wacker
More informationAMA vision for health system reform
AMA vision for health system reform Earlier this year, the American Medical Association put forward our vision for health system reform consisting of a number of key objectives reflecting AMA policy. Throughout
More informationPartnership for Part D Access
Partnership for Part D Access www.partdpartnership.org EXECUTIVE SUMMARY A new study performed by Avalere Health, a leading strategic advisory company, and sponsored by the Partnership for Part D Access
More informationEmployer Health Benefits
57% $5,884 2013 Employer Health Benefits 2 0 1 3 S u m m a r y o f F i n d i n g s Employer-sponsored insurance covers about 149 million nonelderly people. 1 To provide current information about employer-sponsored
More information$5,884 $16,351 THE KAISER FAMILY FOUNDATION - AND - HEALTH RESEARCH & EDUCATIONAL TRUST. Employer Health Benefits. -and- Annual Survey
57% $16,351 THE KAISER FAMILY FOUNDATION - AND - HEALTH RESEARCH & EDUCATIONAL TRUST Employer Health Benefits 2013 Annual Survey $5,884 2013 -and- Primary Authors: KAISER FAMILY FOUNDATION Gary Claxton
More informationAccess to medically necessary healthcare is critical for successful patient outcomes, yet access
ISSUE BRIEF 2 February 2019 Access to Prescription Medications Under Medicare Part D The Patient Access Network Foundation believes that out-of-pocket costs should not prevent individuals with life-threatening,
More informationHealth Insurance Glossary of Terms
1 Health Insurance Glossary of Terms On March 23, 2010, President Obama signed the Patient Protection and Affordable Care Act (PPACA) into law. When making decisions about health coverage, consumers should
More informationFAMILY CYCLE ANALYSIS: Financial Impact of the Senate Health Plan vs. the Affordable Care Act on AI/AN and Other Families
FAMILY CYCLE ANALYSIS: Financial Impact of the Senate Health Plan vs. the Affordable Care Act on AI/AN and Other Families June 29, 2017 This brief examines the financial impact the health insurance legislation
More informationCouncil of State Governments Policy Academy Series. Policy Issues for State Legislators. November 21, 2014
Council of State Governments Policy Academy Series Policy Issues for State Legislators November 21, 2014 What is it all about? 2 What did patient protections and affordable care look like in the 2014 EHB
More informationHealthcare Reform 2010 Major Insurance Market Reform
Healthcare Reform 2010 Major Insurance Market Reform An Independent Licensee of the Blue Cross and Blue Shield Association 2010 Major Insurance Market Reform Table of Contents Pre-Ex Exclusion Periods...
More informationTrump and Affordable Care Act (ACA) Replacement Proposals Trends and Implications
We are your partner in government-sponsored health programs DATE: March 2, 2017 FROM: SUBJECT: Gorman Health Group Policy Team Trump and Affordable Care Act (ACA) Replacement Proposals Trends and Implications
More information2018 RETIREE ANNUAL ENROLLMENT PERIOD 11/15/17 11/29/17
RETIREE WELL BEING FAIR PRESENTATION November 15, 2017 2018 RETIREE ANNUAL ENROLLMENT PERIOD 11/15/17 11/29/17 PLAN DESIGN CHANGES FOR FY19 PLAN YEAR (Effective 03/01/18) TOTAL MEDICAL PLAN COST What was
More informationMEDICARE PART D 2010 DATA SPOTLIGHT COVERAGE OF TOP BRAND-NAME AND SPECIALTY DRUGS
MEDICARE PART D 00 DATA SPOTLIGHT COVERAGE OF TOP BRAND-NAME AND SPECIALTY DRUGS Prepared by Elizabeth Hargrave i ; Jack Hoadley and Laura Summer ii ; and Juliette Cubanski and Tricia Neuman iii SEPTEMBER
More informationCWAG Prescription Drug Pricing Webinar
CWAG Prescription Drug Pricing Webinar January 9, 2018 Kipp Snider, J.D. Vice President, State Policy Pharmaceutical Research & Manufacturers of America (PhRMA) Medicines Are Expected to Account for a
More informationThe Declining Value of Payer Access: Defining and improving Rebate Efficiency in the current healthcare landscape
The Declining Value of Payer Access: Defining and improving Rebate Efficiency in the current healthcare landscape Lucas Greenwalt, Senior Principal Amundsen Consulting Prepared for: CBI Gross to Net Boot
More information4/22/2014. Health Care Reform. Disclosure. Health Care Reform. How Will it Change Your Business Strategy?
Health Care Reform How Will it Change Your Business Strategy? OHCA Educational Session April 29 th, 2014 Presented by: Roderick S. Wood, CHRS Huntington Insurance, Inc. Disclosure This presentation contains
More informationPharmacy Trend Management
Pharmacy Trend Management Strategies for Maximizing the Value of Your Pharmacy Spend Presenter's Name Presentation Date May 1, 2008 Today s speakers Bridget Eber, Pharm.D. Principal and National Pharmacy
More informationMedicare Part D: Saving Money and Improving Health. Delivering on the Promise and Building for the Future
Medicare Part D: Saving Money and Improving Health Delivering on the Promise and Building for the Future DECEMBER 2013 Introduction Medicare Part D offers prescription drug coverage that is delivering
More informationTable of Contents. I. Executive Summary and Introduction..2 A. Overview.2 B. Key Findings...2 C. Summary of Approach...5
Table of Contents I. Executive Summary and Introduction..2 A. Overview.2 B. Key Findings...2 C. Summary of Approach......5 II. III. Detailed Data Analyses Findings...6 A. Louisiana Rankings on Key Metrics....6
More informationThe Affordable Care Act
The Affordable Care Act Employers Guide to 2015 and Beyond For Small Groups Summary Jan. 1, 2014, ushered in new Affordable Care Act (ACA) health insurance market reforms. These changes are impacting the
More informationThe ACA: Health Plans Overview
The ACA: Health Plans Overview Agenda What is the legal status of the ACA? Which plans must comply? Reforms currently in place 2013 compliance deadlines 2014 compliance deadlines 2015 compliance deadlines
More informationRE: Patient Protection and Affordable Care Act; 2017 Notice of Benefit and Payment Parameters
December 18, 2015 Andrew Slavitt Acting Administrator Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 RE: Patient Protection and Affordable Care Act; 2017 Notice
More informationPPACA Implementation and the Marketplaces aka Exchanges. Presented by: Cathy Cooper November 15, 2013
PPACA Implementation and the Marketplaces aka Exchanges Presented by: Cathy Cooper November 15, 2013 Today s Agenda 2014 Provisions Groups over 50 in 2014 Groups under 50 in 2014 Marketplaces aka Exchanges
More informationHEALTH CARE REFORM Focus on Group Coverage Blue Cross and Blue Shield of Minnesota. All rights reserved.
HEALTH CARE REFORM Focus on Group Coverage 2011 Blue Cross and Blue Shield of Minnesota. All rights reserved. Current Insurance Coverage Environment Minnesota United States Uninsured 9% Ot her Public 1%
More informationPatient Protection and Affordable Care Act: HHS Notice of Benefit and Payment Parameters for 2014 Final Rule Summary.
Patient Protection and Affordable Care Act: HHS Notice of Benefit and Payment Parameters for 2014 Final Rule Summary March 21, 2013 On March 11, 2013, the Centers for Medicare & Medicaid Services (CMS)
More informationDeveloping a Sustainable
Developing a Sustainable Retiree Health Plan Strategy By Amy H. Burgoyne and Kim Denbow Medicare Advantage retirees rely on their former employer for medical benefit security. Retiree health plans can
More informationCommercial Risk Adjustment: The most important thing about the ACA that nobody understands
Commercial Risk Adjustment: The most important thing about the ACA that nobody understands Thursday, October 13, 2016 Noon 1:30 Pacific / 1:00 2:30 Mountain / 2:00 3:30 Central / 3:00-4:30 PM Eastern J.
More informationA Publication by the Massachusetts Association of Health Plans. Health Insurance 101 How Are Premiums Developed for Individuals and Small Groups?
OnPoint: Issue Brief A Publication by the Massachusetts Association of Health Plans Volume VIII, April 2017 Written by Eric Linzer Health Insurance 101 How Are Premiums Developed for Individuals and Small
More informationAffordable Care Act and You
Affordable Care Act and You The Affordable Care Act (also called ACA, federal health care reform or sometimes Obamacare ) expands health coverage to millions of previously uninsured Americans and makes
More informationHealth Care Coverage You Need. A Company You Know.
Health Care Coverage You Need. A Company You Know. 2018 Call 800-531-4456, visit bcbstx.com or contact an independent, authorized agent to get a quote today. When It s Time to Get Health Care Coverage,
More informationACA Regulations: Insurance Exchanges and EHBs
ACA Regulations: Insurance Exchanges and EHBs 1 Insurance Exchanges Insurance Exchanges: Exchanges are online marketplaces More than 20 million individuals and employees of small businesses may purchase
More informationPatient Out-of-Pocket Assistance in Medicare Part D: Direct and Indirect Healthcare Savings
Patient Out-of-Pocket Assistance in Medicare Part D: Direct and Indirect Healthcare Savings Avalere Health April 2018 Avalere Health T 202.207.1300 avalere.com An Inovalon Company F 202.467.4455 1350 Connecticut
More informationHealth Care Reform. Navigating The Maze Of. What s Inside
Navigating The Maze Of Health Care Reform What s Inside Questions and Answers on Health Care Reform Health Care Reform Timeline Health Care Reform Glossary Questions and Answers on Health Care Reform I
More informationMedicare Beneficiary Costs Set to Rise for Part D Drug Benefit in 2010
Fact Sheet AARP Public Policy Institute Medicare Beneficiary Costs Set to Rise for Part D Drug Benefit in 2010 Medicare beneficiaries who will participate in Part D for 2010 should examine their plan choices
More informationSurvey Analysis of January 2014 CMS Medicare Part D Proposed Rule
Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule Prepared for: Pharmaceutical Care Management Association Prepared by: Stephen J. Kaczmarek, FSA, MAAA Principal and Consulting Actuary
More informationPRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE
PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE Moderator Audrey Halvorson, Vice Chairperson, Health Practice Council Presenters Karen Bender, Member, Prescription Drug
More informationHealth Benefits Briefing
Health Benefits Briefing Teacher Retirement System of Texas December 7, 2016 Copyright 2015 GRS All rights reserved. TRS-Care Health Care Program For Retired Public School Employees and Their Dependents
More informationAn Overview of the Medicare Part D Prescription Drug Benefit
October 2018 Fact Sheet An Overview of the Medicare Part D Prescription Drug Benefit Medicare Part D is a voluntary outpatient prescription drug benefit for people with Medicare, provided through private
More informationPublic and Private Payer Responses to Pharmaceutical Pricing in the United States
Public and Private Payer Responses to Pharmaceutical Pricing in the United States James C. Robinson Leonard D. Schaeffer Professor of Health Economics Director, Berkeley Center for Health Technology University
More informationHealth Care Coverage You Need. A Company You Know.
Health Care Coverage You Need. A Company You Know. 2018 Call 800-477-2000, visit bcbsil.com or contact an independent, authorized agent to get a quote today. When It s Time to Get Health Care Coverage,
More informationWomen s Coverage, Access, and Affordability: Key Findings from the 2017 Kaiser Women s Health Survey
March 2018 Issue Brief Women s Coverage, Access, and Affordability: Key Findings from the 2017 Kaiser Women s Health Survey INTRODUCTION Since the Affordable Care Act (ACA) went into effect, there has
More informationHealth Service System Board
Health Service System Board Q2 2013 Dashboard Summary Report A Review of City Plan Inpatient, Outpatient, and Rx Trends November 14, 2013 Prepared by Aon Hewitt Health and Benefits Introduction This report
More informationHealth Care Coverage You Need. A Company You Know.
Health Care Coverage You Need. A Company You Know. 2018 Call 855-593-1515, visit www.bcbsmt.com or contact an independent, authorized agent to get a quote today. When It s Time to Get Health Care Coverage,
More informationRetrospective Data Trends and National Benchmarks. Vincent Ng Sr. Manager, Health Business Consulting
Retrospective Data Trends and National Benchmarks Vincent Ng Sr. Manager, Health Business Consulting Disclaimers The information provided is based on an analysis of prescription drug claims processed by
More informationHere are some highlights of the revised Senate language released July 13:
The Better Care Reconciliation Act of 2017, Version 2.0 July 17, 2017 On July 13, Senate Republican leaders released a second working draft of the Senate version of H.R. 1628, the American Health Care
More informationThe impact of California s prescription drug cost-sharing cap
The impact of California s prescription drug cost-sharing cap Prepared by Milliman, Inc. Gabriela Dieguez, FSA, MAAA Principal and Consulting Actuary Bruce Pyenson, FSA, MAAA Principal and Consulting Actuary
More informationList of Insurance Terms and Definitions for Uniform Translation
Term actuarial value Affordable Care Act allowed charge Definition The percentage of total average costs for covered benefits that a plan will cover. For example, if a plan has an actuarial value of 70%,
More information5/5/2014. The Affordable Care Act* 45 th Annual WMSHP Spring Seminar. The Affordable Care Act (ACA) March 23,2010
The Affordable Care Act* 45 th Annual WMSHP Spring Seminar Richard Lichtenstein, PhD, MPH S.J. Axelrod Collegiate Professor of Health Management and Policy University of Michigan School of Public Health
More informationAs pricing actuaries are preparing to price the fourth year
ACA Financial Reporting: The Second Year By Aaron Wright As pricing actuaries are preparing to price the fourth year of Affordable Care Act (ACA) plans, valuation actuaries are still in the process of
More informationAccolade: The Effect of Personalized Advocacy on Claims Cost
Aon U.S. Health & Benefits Accolade: The Effect of Personalized Advocacy on Claims Cost A Case Study of Two Employer Groups October, 2018 Risk. Reinsurance. Human Resources. Preparation of This Report
More informationRealizing Health Reform s Potential
The COMMONWEALTH FUND Realizing Health Reform s Potential AUGUST 2015 Comparing Individual Health Coverage On and Off the Affordable Care Act s Insurance Exchanges Michael J. McCue and Mark A. Hall The
More informationMore Than One-Quarter of Insured Adults Were Underinsured in 2016
Exhibit 1 More Than One-Quarter of Insured Adults Were Underinsured in 216 Percent adults ages 19 64 insured all year who were underinsured* 28 22 23 23 2 12 13 1 23 25 21 212 214 216 * Underinsured defined
More informationMeeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark
Meeting the Health Care Challenges of Tomorrow Jon Roberts Executive Vice President & President, CVS Caremark Agenda PBMs: Needed Now More Than Ever Performance Highlights How We Address Payors #1 Priority:
More informationOVERVIEW PROCESS SERVICES HARVONI. Simply on Your Side. Please see full Prescribing Information, including Patient Information.
HARVONI Simply on Your Side. OVERVIEW PROCESS SERVICES A breakthrough treatment with exceptional support Living with hepatitis C (Hep C) can come with a lot of uncertainty. But getting started with Hep
More informationStanding strong for payers and patients
Standing strong for payers and patients Dr. Steve Miller, SVP, Chief Medical Officer Ben Bier, VP Investor Relations W I L L I A M B L A I R 3 7 TH ANNUAL G ROWTH STOCK C ONFERENCE 6.14.17 1 Safe harbor
More informationThe Shocking Truth Behind ACA Premium Changes: It s Complicated
The Shocking Truth Behind ACA Premium Changes: It s Complicated Audrey L. Halvorson, FSA, MAAA Chair, Rate Review Practice Note Work Group Cori E. Uccello, FSA, MAAA, MPP Senior Health Fellow May 17, 2013
More informationCENTER FOR HEALTH INFORMATION AND ANALYSIS PERFORMANCE OF THE MASSACHUSETTS HEALTH CARE SYSTEM PRIVATE COMMERCIAL CONTRACT ENROLLMENT COVERAGE COSTS
CENTER FOR HEALTH INFORMATION AND ANALYSIS PERFORMANCE OF THE MASSACHUSETTS HEALTH CARE SYSTEM PRIVATE COMMERCIAL CONTRACT ENROLLMENT COVERAGE COSTS COST-SHARING PAYER USE OF FUNDS TECHNICAL APPENDIX 2018
More informationStanding strong for payers and patients
Standing strong for payers and patients Eric Slusser, EVP, Chief Financial Officer Everett Neville, SVP Supply Chain and Specialty B A N K O F A M E R I C A M E R R I L L L Y N C H H E A LTH C A RE CONFERENCE
More informationThe Affordable Care Act: A Summary on Healthcare Reform. The Wyoming Department of Insurance
The Affordable Care Act: A Summary on Healthcare Reform The Wyoming Department of Insurance The ACA is a federal law that impacts Wyoming and its citizens. The State of Wyoming has filed a lawsuit against
More informationAFFORDABLE CARE ACT SMALL EMPLOYER HEALTH REFORM CHECKLIST
www.thinkhr.com AFFORDABLE CARE ACT SMALL EMPLOYER HEALTH REFORM CHECKLIST Small Employer Health Employers that provide health coverage to employees are responsible for complying with many of the provisions
More informationWHITE PAPER. Impact of CSR De-funding on Market Stability. Executive Summary
WHITE PAPER Impact of CSR De-funding on Market Stability Karan Rustagi, FSA, MAAA 720.282.4965 Karan.Rustagi@wakely.com Michael Cohen, PhD 202.568.0633 Michael.Cohen@wakely.com Al Bingham, Jr., FSA, MAAA
More informationAFFORDABLE CARE ACT LARGE EMPLOYER HEALTH REFORM CHECKLIST
www.thinkhr.com AFFORDABLE CARE ACT LARGE EMPLOYER HEALTH REFORM CHECKLIST Employers that provide health coverage to employees are responsible for complying with many of the provisions of the Affordable
More informationALL CARE IS LOCAL DATA FOR MEEKER COUNTY. Data to bring it home
ALL CARE IS LOCAL DATA FOR MEEKER COUNTY People in Meeker County pay for care in many ways: Medicaid in many forms, MinnesotaCare, employer-sponsored and insurance people buy on their own, and Medicare.
More informationHealth Care Reform at-a-glance
Health Care Reform at-a-glance August 2015 Table of Contents Employer mandate...3 Individual mandate...3 Health plan provisions applying to both grandfathered and non-grandfathered employer plans...4 Health
More informationDecember 20, Re: Notice of Benefit and Payment Parameters for 2015 proposed rule. To Whom it May Concern,
December 20, 2013 Centers for Medicare & Medicaid Services U.S. Department of Health and Human Services Attention: CMS-9954-P Hubert H. Humphrey Building 200 Independence Avenue, SW Washington, DC 20201
More informationSession 22 IF, ACA Transitional Solvency Risks. Moderator/Presenter: Samuel C. Vorderstrasse, FSA, MAAA
Session 22 IF, ACA Transitional Moderator/Presenter: Samuel C. Vorderstrasse, FSA, MAAA Presenter: Armen Garnikovich Akopyan, ASA, MAAA 2016 SOA Health Meeting Sam Vorderstrasse, FSA, MAAA Armen Akopyan,
More informationMedicare: The Basics
Medicare: The Basics Presented by Tricia Neuman, Sc.D. Vice President, Kaiser Family Foundation Director, Medicare Policy Project for Alliance for Health Reform May 16, 2005 Exhibit 1 Medicare Overview
More informationH E A L T H C A R E R E F O R M T I M E L I N E
H E A L T H C A R E R E F O R M T I M E L I N E On March 23, 2010, President Obama signed the health care reform bill, or Affordable Care Act (ACA), into law. The ACA makes sweeping changes to the U.S.
More informationExhibit ES-1. Nearly Three of Five Adults Who Lost a Job with Health Benefits in Past Two Years Became Uninsured
Exhibit ES-1. Nearly Three of Five Adults Who Lost a Job with Health Benefits in Past Two Years Became Uninsured Percent of adults ages 19 64 Total
More informationStrategies for Assessing Health Plan Performance on Chronic Diseases: Selecting Performance Indicators and Applying Health-Based Risk Adjustment
Strategies for Assessing Health Plan Performance on Chronic Diseases: Selecting Performance Indicators and Applying Health-Based Risk Adjustment Appendix I Performance Results Overview In this section,
More informationFor our next section for Introduction to Current Risk Adjustment Model and Model Exploration Topics. We have joining us, two additional CMS speakers.
HHS-Operated Methodology Meeting ARDX Facilitator: Dot Claytor CMS Presenters: Krutika Amin and Kelly Drury For our next section for Introduction to Current Model and Model Exploration Topics We have joining
More informationA special look at health care reform. Helping members make informed decisions. Special Edition 2013
Special Edition 2013 SM Helping members make informed decisions A special look at health care reform. Changes ahead 3 How health care reform will impact rates 6 Five ways health care reform may affect
More informationRulemaking implementing the Exchange provisions, summarized in a separate HPA document.
Patient Protection and Affordable Care Act: Standards Related to Reinsurance, Risk Corridors and Risk Adjustment Summary of Proposed Rule July 15, 2011 On July 15, 2011, the Department of Health and Human
More information2018 ACA Marketplace Premiums Jonathan Keisling December 20, 2017
2018 ACA Marketplace Premiums Jonathan Keisling December 20, 2017 Executive Summary This study analyzes the 2018 premium increases for health insurance plans offered on the Affordable Care Act s individual
More informationWorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond. Kristin Begley, Pharm.D. Principal
WorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond Kristin Begley, Pharm.D. Principal Presentation Overview The future of drug trend Prescription drug management levers: Contracting
More informationReinsurance and Cost-Sharing Reductions Estimates
Reinsurance and Cost-Sharing Reductions Estimates May 9, 208 In response to the 208 premium increases in the Affordable Care Act s individual market, members of Congress have written various pieces of
More informationUpdate on the Affordable Care Act. Kevin Shah, MD MBA. Review major elements of the affordable care act
Update on the Affordable Care Act Kevin Shah, MD MBA 1 Goals Review major elements of the affordable care act Review implementation of the Individual Exchange Review the Medicaid expansion Discuss current
More informationSan Francisco Health Service System Health Service Board
San Francisco Health Service System Health Service Board HSS Rates & Benefits Committee Meeting City Plan (UHC) Employer Group Waiver Plan (EGWP) + Wrap Presentation April 12, 2012 Prepared by Aon Hewitt
More informationIMPLICATIONS OF THE AFFORDABLE CARE ACT FOR COUNTY EMPLOYERS
IMPLICATIONS OF THE AFFORDABLE CARE ACT FOR COUNTY EMPLOYERS Mississippi Association of Supervisors Annual Convention Biloxi, Mississippi June 20, 2013 Presented by Leslie Scott MAS General Counsel Group
More informationHealth Care in California: The Chronically Ill
Health Care in California: The Chronically Ill A report for the California HealthCare Foundation prepared by Prepared for the California HealthCare Foundation by Harris Interactive Contents About this
More informationQuantifying Tax Credits for People Now Buying Insurance on Their Own
issue brief Quantifying Tax Credits for People Now Buying Insurance on Their Own August 2013 A number of states have recently released information on what premiums will be in the individual insurance market
More informationARKANSAS BLUE CROSS and BLUE SHIELD
Reason for Requesting Rate Increase Arkansas Blue Cross and Blue Shield is filing a modified rate request for 2018 in response to the Arkansas Insurance Department (AID) Bulletin number 14-2017 dated August
More informationThe Health Insurance Market in Virginia. Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017
The Health Insurance Market in Virginia Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017 Anthem Inc. at a Glance Broad geographic footprint and customer base ` BCBS plans
More information